Boost Your US BUYS $290 MILLION WORTH OF DRUGS FOR USE IN RADIOLOGICAL AND NUCLEAR EMERGENCIES With These Tips
The HHS Strategic Preparedness and Response Administration announced in a statement Tuesday that it has purchased Enplate drug from Amgen USA Inc.
Acute radiation syndrome, which is caused by exposure to high doses of radiation, can cause a variety of symptoms.
According to the Centers for Disease Control and Prevention, severe cases can have devastating effects on the body, including bone marrow destruction and internal bleeding.
Enplate, which can be used in both adults and children, aims to reduce the uncontrolled bleeding that is often caused by radiation.
US officials have insisted Washington would take decisive action if Russia proceeds to use nuclear weapons and warned of dire consequences for Putin.
UN Secretary-General Antonio Guterres last month called for an end to the "era of nuclear blackmail" and the global elimination of nuclear weapons.
The Food and Drug Administration first approved the drug in 2008 to combat an autoimmune disorder that causes severe bleeding and extended another approval in January last year for the drug's use to treat radiation sickness.
The new purchase follows growing international concern over the possible use of nuclear weapons in Russia's war against Ukraine.
Russian President Vladimir Putin recently threatened that his country would take all necessary steps to claim victory and would not hesitate to deploy nuclear weapons.